Epitranscriptomic analysis reveals features of NAD-capped RNAs upon supplementation of nicotinamide mononucleotide in human
- Exp Cell Res. 2025 Oct 8;453(1):114780. doi: 10.1016/j.yexcr.2025.114780.
- 1. Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 100 Hai Ke Rd., Pudong, Shanghai, 201210, China; University of Chinese Academy of Sciences, Beijing, 100049, China.
- 2. Department of Vascular and Endovascular Surgery, Chang Zheng Hospital, Naval Medical University, Shanghai, 200003, China.
- 3. Redpont Biotechnology, Hongtaiyang Life Science Industrial Park, Dangtu Economic Development Zone, Ma'anshan, Anhui Province, 243000, China.
- 4. Haven Biotechnology, 1 Jing Ba Rd, Economic Development Zone, Ganzhou, Jiangxi Province, 342499, China.
- 5. Singlera Genomics, 500 Fu Rong Hua Rd., Pudong, Shanghai, 201204, China.
- 6. Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 100 Hai Ke Rd., Pudong, Shanghai, 201210, China; Shanghai Key Laboratory of Aging Studies, 100 Hai Ke Rd., Pudong, Shanghai, 201210, China.
- 7. Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 100 Hai Ke Rd., Pudong, Shanghai, 201210, China; Shanghai Key Laboratory of Aging Studies, 100 Hai Ke Rd., Pudong, Shanghai, 201210, China. Electronic address: [email protected].
- 8. Department of Vascular and Endovascular Surgery, Chang Zheng Hospital, Naval Medical University, Shanghai, 200003, China. Electronic address: [email protected].
Nicotinamide mononucleotide (NMN), a precursory metabolite of NAD, has been demonstrated to boost cellular NAD level that is coupled with various age-related beneficial effects in animal models. NAD-capped RNA (NAD-RNA) represents a critical but poorly studied modification at the epitranscriptomic level. Here we examine the impact of NMN supplementation on NAD-RNA in human peripheral blood mononuclear cells (PBMCs). We demonstrated that NMN supplementation increases NAD turnover coupled with a reduction in NAD-capped RNAs in both human and dog, revealing blood-derived NAD-RNAs as potential biomarkers sensitized to NMN exposure.
-
Cat. No.Product NameCategory/Application